Celcuity (CELC) Tax Rate (2018 - 2020)

Celcuity's (CELC) quarterly Tax Rate came in at 78.01% in Q4 2020, down 739.0% YoY from 12.21% in Q1 2020, and down 8.66% on a QoQ basis from 85.41% in Q4 2019.

Celcuity (CELC) Tax Rate (2018 - 2020) Analysis & Trends

Celcuity (CELC) has 3 years of Tax Rate data on file, last reported at 78.01% in Q4 2020.

  • Quarterly Tax Rate fell 739.0% year-over-year to 78.01% in Q4 2020, while the trailing twelve-month figure through Jun 2021 was 9.11% (down 964.0% YoY) and the FY2025 annual result came in at 21.0%, up 2160.0% from the prior year.
  • Tax Rate slipped to 78.01% in Q4 2020, from 85.41% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 86.07% in Q4 2018 to a low of 78.01% in Q4 2020.
  • A 3-year average of 83.16% and a median of 85.41% in 2019 frame the typical range for Tax Rate.
  • Annual changes were most pronounced in 2019 — Tax Rate slumped 66 bps — and 2020, when it slumped 739 bps.
  • Tracing CELC's Tax Rate over 3 years: stood at 86.07% in 2018, then slipped by 1 bps to 85.41% in 2019, then fell by 9 bps to 78.01% in 2020.
  • The last three Tax Rate figures came in at 78.01% (Q4 2020), 85.41% (Q4 2019), and 86.07% (Q4 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 15.11%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.91%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 24.15%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -9.47%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 7.49%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -16.71%
10 Celcuity 4.50 Bn 4.50 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 78.01%
Dec 31, 2020 78.01%
Dec 31, 2020 78.01%
Dec 31, 2019 85.41%
Dec 31, 2019 85.41%
Dec 31, 2019 85.41%
Dec 31, 2018 86.07%
Dec 31, 2018 86.07%
Dec 31, 2018 86.07%